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STUDY of the effects of toxic agents on the liver has given us a considerable
body of knowledge about the histological and biochemical abnormalities resulting
from the action of specific drugs. Less is known about what happens if these are
given concurrently nor do we know whether their individual effects on hepatic
tissue are retained or merged with one another. Such studies might well supply
new data concerning both their modes ofaction and also the reactions ofliver cells
to damage, in the same way as Rous and Larimore's (1920) experiments combining
portal vein ligation with bile duct obstruction produced a result unpredictable
from the known effects of ligation of each separately.
In a previous paper (Sutton, 1960) the combination of carbon tetrachloride
(CC14) and c-naphthyl-isothiocyanate (ANI) was used. This gave disappointing
results for there was merely a summation oftheir individual effects. The present
paper describes the action ofrepeated doses ofCC14 on the rat liver already under-
going carcinogenesis by feeding with p-dimethylaminoazobenzene (butter yellow,
DAB). In view of the known association between cirrhosis of the liver and
hepatic cancer, it was suspected that CC14, which produces liver necrosis as an
acute effect and cirrhosis as a chronic, might alter the pattern of carcinogenesis
induced by DAB. Also, unlike ANI which acts almost entirely on the bile ducts,
both CC14 and DAB affect the hepatic parenchymal cells, and it was wondered
how they would respond to this double injury. In a paper dealing mainly with
the effects of different diets on liver tumours induced by DAB, Miller et al. (1941)
reported thatsubcutaneous injections ofCC14 had no obvious effectonlivertumour
production (though CC14 given prior to DAB may have slightly increased the
rate of tumour formation).
MATERIALS AND METHODS
OnehundredandthreeadultWistaralbinorats ofbothsexes wereused, theaver-
age weight at the start-of the experiment was 150 g. The animals were split into
three groups: 45 rats received both DAB and CC14, 38 DAB alone and 20 CC14
alone. DAB was mixed with MRC powder 41 in a concentration of 0 06 per
cent. CC14 was given by Forbes' (1939) inhalation method once a week commenc-
ing two weeks after the rats had started DAB feeding, and continued for 24 weeks
except for a gap of 3 weeks following the 14th week when no CC14 was given,
though DAB feeding continued. All animals had access to unlimited water.
Rats were weighed regularly and killed by excess ether at appropriate intervals
throughout the experiment up to 36 weeks; if they were receiving both DABP. M. SUTTON
and CC14 they were killed 7 days after the last inhalation of CC14. Six rats died
and were useless for histology because of autolysis. Careful post mortem exami-
nations were made and material taken for histology from liver, spleen, lung and
kidney as aroutine, together with any other organs appearing abnormal. Sections
were cut at 5 It, and stained with Ehrlich's acid haematoxylin and eosin (H. and
E.), Van Gieson's method, silver impregnation for reticulin and periodic-acid-
Schiff (PAS).
RESULTS
Weekly inhalations ofCC14 administered to rats already on a DAB-containing
diet produced a marked contrast in the early histological changes in the liver
by comparison with those induced by DAB alone. When DAB alone is fed,
changes occur in both the biliary system and the hepatic parenchyma. The
earliest changes are those ofbile duct proliferation, which may be extreme giving
a cirrhotic-like histological picture plus certain focal bile duct lesions which will
be considered in more detail below. Meanwhile, the parenchymal cells undergo
progressive alterations in their nuclei and cytoplasm, with the eventual appear-
ance of nodules of hyperplastic liver cells. Finally, after about 6 months
malignant tumours arise, the majority of parenchymal cell origin but with some
cholangiocarcinomas. The essential differences between the two main groups
of rats, those on DAB plus CC14 and those on DAB alone were of a quantitative
rather than a qualitative nature. Since no special histological features were
discovered which would warrant a detailed pathological description the results
will be presented as a comparison between these two groups of animals, using the
terminology employed by Opie (1944) and Firminger (1955) in their accounts of
DAB carcinogenesis. Even inside each of the two main groups, considerable
variation existed from animal to animal in the degree of hepatic change found
in rats killed at the same time. Accordingly the findings will be given at three
monthly intervals so that the groups are sufficiently big to make the results
significant. The third group of rats receiving only weekly inhalations of CC14
showed the typical zonal areas of centrilobular liver necrosis 24 hours after ad-
ministration of the toxic agent, with complete regeneration over the next 7 days
before the next dose. When these rats were killed 10 days after the last of
24 weekly attacks of CC14 induced necrosis, their livers showed no abnormality
and in particular no cirrhosis (Fig. 1). In the results described below animals
on CC14 alone will not be considered further.
Months 1-3.-The most marked difference was the far greater degree of bile
duct activity found in animals on DAB plus CC14 compared with those on DAB
alone. About one half of the rats receiving the former treatment developed the
striking lesion called by Opie (1944) cholangiofibrosis (Table I). Here foci of
hyperplastic bile ducts with frequent mitoses lay in a cellular stroma of young
TABLE I.-Incidence of Cholangiofibrosis (C.F.) in Rats
DAB + CC14 DAB only
Months Total With C.F. Total With C.F.
1-3 . 15 7 . 14 0
4-6 . 12 10 . 12 1
7-9 . 14 12 . 10 7
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fibroblasts and capillaries (Fig. 2). Often a column of bile duct cells enclosed
collections ofPAS-positive mucus, containing small groups of polymorphs whilst
the whole lesion was infitrated withplasma cells. On purelyhistologicalgrounds
the early nodules of cholangiofibrosis do resemble malignant tumours of bile
ducts but this question will be taken up later in this paper. No cholangiofibrosis
was found at this stage in rats on DAB alone and because these cholangiofibrotic
areas are easily seen macroscopically as depressed white scars often near the
liver surface, as Gupta (1956) has emphasized, it is unlikely that any were over-
looked at autopsy. Together with this increase in cholangiofibrosis, animals
receiving both drugs showed a greater degree of bile duct proliferation sometimes
in adenomatous groups such as Orr (1940) described, and even in those rats
without such extreme bile duct activity there was a greater degree ofproliferation
ofsmall, dark-staining spindle-shaped cells called by Farber (1956b) "oval cells "
and probably of biliary origin, extending deep into the lobules from the portal
tracts. By contrast, rats on DAB only showed slighter bile duct activity and
fewer oval cells extending from portal areas (Fig. 3). However, no significant
difference was detected in the parenchymal cells between the two groups. Both
showed small islands of enlarged liver cells with loss of cytoplasmic basophilia
and nuclei up to double their normal size with prominent nucleoli and occasional
cell divisions, though no abnormal mitotic figures were found. Almost no ne-
crosis was detected in rats on DAB alone; an occasional cell with brightly eosino-
philic cytoplasm and a pyknotic nucleus was seen (individual cell necrosis) but
nothing more. No animals in either group developed malignant tumours during
this period.
Months 4-6.-By now the majority of rats receiving DAB with CC14 had
developed cholangiofibrosis, whereas only one of the animals receiving DAB
alone showed this lesion (TableI). At this time these areas of cholangiofibrosis
were larger and the more central bile ducts were less hyperplastic with fewer
mitoses and less hyperchromatic than the foci of cholangiofibrosis found during
the first three months (Fig. 4). In places this trend had continued to a dense
fibrosis in the middle of the lesion (Fig. 5), with acellular collections of mucus and
small islands of hepatic cells trapped in the fibrous tissue. Once again the
animals receiving both toxic agents showed the greater degree ofbile duct activity
and again there was no difference in the appearance of the parenchymal cells
between the twogroups. By this time both sets ofanimals had nodules ofactively
growing liver cells, with great nuclear variation and quite frequent cell divisions
in which occasional abnormal mitoses, in the form of chromosomal bridges, were
found. In no case were these nodules sufficiently large or atypical enough to be
classified as malignant tumours. A few rats on DAB plus CC14, but none on
DAB alone, had enough fibrous tissue formation accompanying the bile duct
proliferation, with sufficient distortion of the hepatic architecture on Van Gieson
and reticulin staining to warrant the description of portal cirrhosis.
Months 7-9.-From the 24th week until the 36th week when the experiment
was concluded the animals in both groups developed malignant tumours of the
liver. No metastases were detected, but this was probably because the rats were
killed once an abdominal mass was palpated. No significant difference was
detected in either the induction time or in the final incidence of liver cancer be-
tween the two groups, 11 out of 14 rats on DAB plus CC14 compared with 9 out
of 10 rats on DAB alone developing malignant tumours. At this stage, as Table I
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shows, there was now little difference in the incidence of cholangiofibrosis though
these areas were usually larger in animals exposed to both drugs.
Regarding the type of liver tumour induced the histological picture showed
so much variability in different areas from the same liver that classification was
not easy. In general terms, the following conclusions were drawn:
(a) In both groups the commonest tumour was one showing a pleomorphic
pattern ranging from hepatocarcinoma to the adenohepatoma of other authors.
In a minority there was a definitely cholangiocarcinomatous component. All
the tumours showed much necrosis, frequent mitoses with many abnormal forms
and tumour giant cells.
(b) Some tumours were of a purely hepatocellular type with a patterln similar
to that of embryonic liver and including small islands of haemopoiesis. No bile
secretion was detected. These tumours sometimes developed in livers containing
nodules of cholangiofibrosis and were so morphologically different from the
latter that it was difficult to conceive that they had arisen from them. On the
other hand, in rats on DAB alone frank hepatocarcinomas were found in 2 animals
in which no cholangiofibrosis at all was present (Fig. 6).
(c) A minority ofthe tumours were of a purely cholangiocarcinomatous pattern
(Fig. 7). In at least two rats the histology strongly suggested that a cholangio-
carcinoma had arisen from an area of cholangiofibrosis.
Other findings. In both groups the spleen was enlarged to several times the
normal size; microscopy showed extreme congestion of the red pulp with large
islands of haemopoietic cells. A few rats in both groups developed a chronlic
inflammatory lesion in the caecum similar to that described by Orr (1940). Rats
on DAB alone gained more weight (mean +110 g.) than those on DAB plus C(CI4
(mean +60 g.).
DISCUSSION
In experimental work on liver tumours the nature of the lesion termed cholan-
giofibrosis has been disputed. The word was coined by Opie (1944), who implied
a precancerous condition in his account of the pathogenesis of the tumours pro-
duced by DAB; a similar view was taken by Gupta (1956) in studies of the
effect ofthioacetamide on rat liver. Price et al. (1952), describing the progressive
histological alterations occurring after azo-dye feeding found that regardless of
type, liver tumours always arose in an area of cholangiofibrosis. However. Fir-
EXPLANATION OF PLATES
FiG. 1 -Norinal liver from CC14 control, 10 days after 24 weekly inhalations ofCC14. H. and E.
x 184.
FIG. 2. Area of cholangiofibrosis showing hyperplastic biliary epithelium around a central
plug of mucus and polymorphs. Nine weeks DAB plus CC14. H. and E. x 184.
FIG. 3. Early bile duct and " oval " cell proliferation but no cholangiofibrosis. Nine weeks
DAB alone. H. and E. x 184.
Fic. 4. Larger area of cholangiofibrosis. Fourteen weeks DAB plus CC14. H. and E.
x 184.
FIG. 5. Central portion of a cholangiofibrotic nodule showing small clumps of hepatic pareln-
chymal cells in relatively acellular fibrous tissue. H. and E. x 175.
FIG. 6. Hepatocarcinoma, showing a sheet of uniform cells of parenchymal cell origin with
mitotic figures. Thirty-five weeks DAB only. H. and E. x 385.
FIG. 7. Cholangiocarcinoma with an alveolar pattern and tumour giant cells. Thirty-two
weeks DAB plus CCl4. H. and E. x 385.
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minger's (1955) experience of both DAB and 2-acetylaminofluorene (AAF) was
that although cholangiocarcinomas did arise in areas of cholangiofibrosis,
yet
they comprised only a small minority of the induced liver tumours. Farber
(1956a), using ethionine, noted the histological simulation of cancer by areas of
cholangiofibrosis but believed that these were not true tumours. On the other
hand, both Orr (1940) and Grant and Rees (1958) considered this lesion a frank
cholangiocarcinoma; whilst White and Edwards (1942) argued that it was not
a tumour at all, because it was not transplantable, it neither invaded blood
vessels nor metastasised and progressed through atrophic changes to eventual
fibrosis. Popper and Schaffner (1957), in their review agree that cholangiofibrosis
should not be regarded as neoplastic.
It appears from the experiments reported here on combined DAB and CC14
intoxication that cholangiofibrosis is not a necessary precursor of cancer of the
liver because (a) some animals developed malignant tumours in the absence of
this lesion, and (b) the increased induction of cholangiofibrosis by DAB PlUS CCI4
was not associated with an increased production of liver cancer. However, in a
minority of the animals frank cholangiocarcinomas did arise in areas of cholangio-
fibrosis.
GrantandRees(1958)describedan increasedincidence ofcholangiocarcinoma
(this is their terminology for what is here called cholangiofibrosis in what follows
the term cholangiofibrosis will be used for the sake of clarity) in rats fed DAB and
a normal diet compared with another group given DAB plus supplemented B
vitamins. In their description of the early changes in the liver much moreparen-
chymal cell necrosis was observed in those animals without added vitamins which
developed cholangiofibrosis. This is interesting since in the present experiment
the ratsgiven DAB plus CC14whichshowedtheearliestand greatest incidence of
cholangiofibrosis also had moreparenchymal cellnecrosis due to the acute effects
ofCC14. In thepresent investigation it is not yet known whether the necrosis
inducedbyCC'4ortheamountsofBvitaminsingestedwereofgreaterimportance.
Hypovitaminosis cannot be excluded, especially as the animals receiving both
toxic compounds gained less weight than those fed DAB alone.
It is not immediately obvious why the addition of repeated doses ofCC14
to animals already receiving DAB should affect the bile ducts and connective
tissue of the portal tracts rather than the parenchymal cells. The problem is
similar to the classical one ofchronic CC14 poisoning and subsequent portal cir-
rhosis whererepeated centrilobular necrosis gives rise to cirrhosis (Cameron and
Karunaratne, 1936). As Cameron and Karunaratne observed, if sufficient time
elapses between theCC14injectionsfortheliverto recover (i.e. to regenerate and
fill up the necrosed zones with new cells) then no cirrhosis results however long
the experiment is continued. In this present work control rats given weekly
CC14 for 24 weeks did not develop cirrhosis, whereas previously (Sutton, 1960)
rats given approximately the same amount ofCC14 twice weekly developed the
histologicalpicture ofportal cirrhosis by 12 weeks. Cameron and Karunaratne
suggestedthatthecirrhosiswasduetostimulationoftheperiportal fibrous tissue
by thepassage there oftheproducts ofautolysis from the necrotic centrilobular
zones.
When liver tissue is lost, e.g. by partial hepatectomy, there is evidence that
theresidueisstimulatedintoactiveregenerationeitherbythedropin concentra-
tion of acirculating tissue-specific growth inhibitor (Weiss andKavanau, 1957;
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Glinos, 1958) or by the rise in blood levels of growth stimulating factors (Cameron,
1955; Weinbren, 1959). Abercrombie and Harkness (1951) have shown that
following partial hepatectomy parenchymal cells undergo a burst of mitotic
activity, maximum at 24 hours, followed at 48 hours by a second smaller peak
in bile duct epithelium, sinusoidal cells and probably fibroblasts around portal
tracts. This suggests strongly that these non-parenchymal liver cells are also
regulated by factors similar to those that control the growth of hepatic paren-
chymal cells, but that their response is neither so great nor so rapid as the latter.
Abercrombie (1957) thinks that this involves the existence of definite organ races
of connective tissue cells and quotes the work of Grobstein (1953) on tissue culture
studies on embryonic induction in support of his hypothesis.
This proliferation of portal tract tissue after hepatectomy suggests an alter-
native explanation to that of a stimulation by autolytic tissue for the production
of cirrhosis byCC14: that the sustained lack ofliver tissuewill result in prolonged
specific activation ofthe non-parenchymal hepatic cells by the circulating factors,
thus giving the mixture offibroblastic, vascular and biliary proliferation found in
cirrhosis. Such a situation arises with twice weekly CC14 intoxication whereas
with less frequent doses the liver is able to regenerate completely and the cir-
culating factors return to normal and the less responsive non-parenchymal cells
are not stimulated. This model explains why the earliest proliferative changes in
portal cirrhosis are periportal since the circulating factors reach this zone of the
liver lobule first. It can possibly account for the portal cirrhosis found after pro-
longedfatty infiltration of the liver, in which necrosis is absent, by assuming that
the degenerate fatty cells fail either to produce or to respond to the circulating
factors, so that a slow proliferative response is provoked in the non-parenchymal
elements. Perhaps, too, when liver carcinogens act on parenchymal cells with
the eventual production of carcinomas a similar interference with the growth
controlling mechanisms results so that the initial bile duct proliferation is an
indicator of this primary action. Farber (1956b) has shown that the earliest
changes found in the livers of rats fed either DAB, AAF or ethionine are bile
duct and "oval" cell proliferation (the latter of probable biliary origin) without
parenchymal cell necrosis. Many workers (e.g. Miller and Miller, 1953) have
suggested that carcinogens act through damage to the specific cellular mechanisms
controlling growth. The idea here is that the initial excessive bile duct activity
found by giving CC14 together with DAB is accounted for by both substances
affecting thesegrowthcontrolling mechanisms in different ways, CC14 by producing
necrosis and DAB by specific damage to these mechanisms short of actual cell
death.
SUMMARY
1. Rats were exposed to weekly inhalations of CC14 whilst receiving DAB in
their diets over a period of months.
2. This resulted in much greater bile duct proliferation and the earlier appear-
ance ofcholangiofibrosis than found in rats on DAB alone; but no difference in
either theparenchymal cells or in the final production of tumours. Some hepato-
carcinomas arose in livers in which no cholangiofibrosis was present. Therefore,
in these experiments cholangiofibrosis did not appear to be an essential precursor
of liver cancer, although a few instances of cholangiocarcinomas arising in areas
of cholangiofibrosis were found.
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3. The excessive bile duct activity in rats fed DAB, following weekly CCJ4-
induced parenchymal cell necrosis, is compared with the portal cirrhosis found
with chronic CCl4 intoxication and the underlying mechanisms discussed.
I wish to thank Sir Roy Cameron for constant help and advice during this
work, Dr. J. F. Smith and Dr. W. G. Spector for helpful criticism of the manu-
script and Miss Angela Clufffor skilled technical assistance throughout. Grateful
acknowledgement is made to the British Empire Cancer Campaign for a grant
covering the expenses of this investigation. This work was carried out during
the tenure of the Charles Bolton Fellowship.
REFERENCES
ABERCROMBIE, M.-(1957) Symp. Soc. exp. Biol., 11, 235.
Idem AND HARKNESS, R. D.-(1951) Proc. Roy. Soc. B., 138, 544.
CAMERON, G. R.-(1955) in 'Lectures on the Scientific Basis of Medicine'. London
(Athlone Press), vol. 3, p. 52.
Idem AND KARuINARATNE, W. A. E.-(1936) J. Path. Bact., 42, 1.
FARBER, E.-(1956a) Arch. Path., 62, 445.-(1956b) Cancer Res., 16, 142.
FIRMINGER, H. I.-(1955) J. nat. Cancer Inst., 15, 1427.
FORBES, J. C.-(1939) J. Pharmacol., 65, 287.
GLINos, A. D.-(1958) in 'Liver Function'. Edited by R. W. Brauer. Washington
(American Institute of Biological Sciences), p. 425.
GRANT, H. C. AND REES, K. R.-(1958) Proc. Roy. Soc. B., 148, 117.
GROBSTEIN, C.-(1953) Science, 118, 52.
GUPTA, D. N.-(1956) J. Path. Bact., 72, 415.
MILLER, J. A. AND MILLER, E. C.-(1953) in 'Advances in Cancer Research'. Edited
by J. P. Greenstein and A. Haddow. New York (Academic Press), vol. 1, p. 340.
Idem, MINER, D. L., RusCH, H. P. and BAUMANN, C. A.-(1941) Cancer Res., 1, 699.
OPIE, E. L.-(1944) J. exp. Med., 80, 231.
ORR, J. W.-(1940) J. Path. Bact., 50, 393.
POPPER, H. AND SCHAFFNER, F.-(1957) in' Liver Structure and Function'. New York
(McGraw-Hill), p. 597.
PRICE, J. M., HARMAN, J. W., MILLER, E. C. AND MILLER, J. A.-(1952) Cancer Re8.,
12, 192.
Rous, P. AND LARIMORE, L. D.-(1920) J. exp. Med., 31, 609.
SUTTON, P. M.-(1960) J. Path. Bact., 79, 157.
WEINBREN, K.-(1959) Gastroenterology, 37, 657.
WEISS, P. AND KAVANAU, J. L.-(1957) J. gen. Physiol., 41, 1.
WHITE, J. AND EDWARDS, J. E.-(1942) J. nat. Cancer Inst., 3, 43.